Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Berger

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
AJNR. American Journal of Neuroradiology|April 16, 2003
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphomaJoseph R Berger
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 23, 2019
PML with dimethyl fumarate-No role for natalizumab?Joseph R Berger
The American Journal of Managed Care|July 19, 2011
Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapiesJoseph R Berger
Neurology|August 12, 2011
Too much of a good thing? IRIS with natalizumab-associated PMLJoseph R Berger
Cleveland Clinic Journal of Medicine|November 30, 2011
The clinical features of PMLJoseph R Berger
Handbook of Clinical Neurology|September 24, 2008
Progressive multifocal leukoencephalopathyJoseph R Berger
Drug Safety|October 8, 2010
Progressive multifocal leukoencephalopathy and newer biological agentsJoseph R Berger
Continuum (Minneapolis, Minn.)|July 20, 2012
Infectious myelopathiesJoseph R Berger
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 24, 2012
The interface of infectious disease and neuro-ophthalmologyJoseph R Berger
JAMA Neurology|June 5, 2013
Neurologists: the last bedside physician-scientistsJoseph R Berger
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
AJNR. American Journal of Neuroradiology|April 16, 2003
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphomaJoseph R Berger
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 23, 2019
PML with dimethyl fumarate-No role for natalizumab?Joseph R Berger
The American Journal of Managed Care|July 19, 2011
Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapiesJoseph R Berger
Neurology|August 12, 2011
Too much of a good thing? IRIS with natalizumab-associated PMLJoseph R Berger
Cleveland Clinic Journal of Medicine|November 30, 2011
The clinical features of PMLJoseph R Berger
Handbook of Clinical Neurology|September 24, 2008
Progressive multifocal leukoencephalopathyJoseph R Berger
Drug Safety|October 8, 2010
Progressive multifocal leukoencephalopathy and newer biological agentsJoseph R Berger
Continuum (Minneapolis, Minn.)|July 20, 2012
Infectious myelopathiesJoseph R Berger
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 24, 2012
The interface of infectious disease and neuro-ophthalmologyJoseph R Berger
JAMA Neurology|June 5, 2013
Neurologists: the last bedside physician-scientistsJoseph R Berger
Pageof 21